Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Levacher

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1986
Diethyldithiocarbamate provides partial protection against pulmonary and lymphoid oxygen toxicityH Mansour, M Levacher, M A Gougerot-Pocidalo, et al.
Clinical and Experimental Immunology|November 1, 1983
Characterization of immunological depression in mice exposed to normobaric oxygenM Levacher-Place, M A Gougerot-Pocidalo, B Rouveix, et al.
Clinical and Experimental Immunology|August 1, 1990
T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDSM Levacher, S Tallet, M C Dazza, et al.
Clinical and Experimental Immunology|December 1, 1992
The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic valueM Levacher, F Hulstaert, S Tallet, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 1, 1988
Genetic differences in response to pulmonary cytochrome P-450 inducers and oxygen toxicityH Mansour, M Levacher, E Azoulay-Dupuis, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
Cytofluorometric analysis of chondrotoxicity of fluoroquinolone antimicrobial agentsG Hayem, P X Petit, M Levacher, et al.
Therapie|March 10, 2001
[Antibacterial activity of urine after administration of ofloxacin for 5 days]H Drugeon, M L Veyries, M Levacher, et al.
Rheumatology (Oxford, England)|October 16, 2001
Low levels of nitric oxide (NO) in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cellsY Allanore, D Borderie, P Hilliquin, et al.
Clinical and Experimental Immunology|November 1, 1994
Interactions between murine AIDS (MAIDS) and toxoplasmosis in co-infected miceC Lacroix, M Levacher-Clergeot, F Chau, et al.
AIDS Research and Human Retroviruses|January 1, 1996
Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1F Bouscarat, M Levacher-Clergeot, M C Dazza, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1986
Diethyldithiocarbamate provides partial protection against pulmonary and lymphoid oxygen toxicityH Mansour, M Levacher, M A Gougerot-Pocidalo, et al.
Clinical and Experimental Immunology|November 1, 1983
Characterization of immunological depression in mice exposed to normobaric oxygenM Levacher-Place, M A Gougerot-Pocidalo, B Rouveix, et al.
Clinical and Experimental Immunology|August 1, 1990
T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDSM Levacher, S Tallet, M C Dazza, et al.
Clinical and Experimental Immunology|December 1, 1992
The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic valueM Levacher, F Hulstaert, S Tallet, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 1, 1988
Genetic differences in response to pulmonary cytochrome P-450 inducers and oxygen toxicityH Mansour, M Levacher, E Azoulay-Dupuis, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
Cytofluorometric analysis of chondrotoxicity of fluoroquinolone antimicrobial agentsG Hayem, P X Petit, M Levacher, et al.
Therapie|March 10, 2001
[Antibacterial activity of urine after administration of ofloxacin for 5 days]H Drugeon, M L Veyries, M Levacher, et al.
Rheumatology (Oxford, England)|October 16, 2001
Low levels of nitric oxide (NO) in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cellsY Allanore, D Borderie, P Hilliquin, et al.
Clinical and Experimental Immunology|November 1, 1994
Interactions between murine AIDS (MAIDS) and toxoplasmosis in co-infected miceC Lacroix, M Levacher-Clergeot, F Chau, et al.
AIDS Research and Human Retroviruses|January 1, 1996
Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1F Bouscarat, M Levacher-Clergeot, M C Dazza, et al.
Pageof 3